NANOCAN IS CURRENTLY DEVELOPING NEW PRODUCTS TO TREAT 7 SOLID CANCER INDICATIONS.

In collaboration with leading cancer research institutions, Nanocan is conducting pre-clinical research and development of its unique product formulations targeted at a variety of cancer indications. The table below illustrates Nanocan’s product development pipeline.